摘要 |
The invention relates generally to compounds which are allosteric modulators (e.g., negative and positive allosteric modulators, allosteric agonists, and ago-allosteric modulators) of the G protein coupled receptor CXCR5. The CXCR5 receptor compounds are derived from the intracellular loops and domains of the CXCR5 receptor. The invention also relates to the use of these CXCR5 receptor compounds and pharmaceutical compositions comprising the CXCR5 receptor compounds in the treatment of diseases and conditions associated with CXCR5 receptor modulation such as autoimmune diseases including lupus, HIV and rheumatoid arthritis, Primary Sjogren's Syndrome, chronic lymphocytic leukemia, Burkitt Lymphoma, colon and breast cancer tumor metastasis, Multiple Sclerosis and compromised immune function. |
申请人 |
ANCHOR THERAPEUTICS, INC.;MCMURRY, THOMAS, J.;KULIOPULOS, ATHAN;COVIC, LIDIJA |
发明人 |
MCMURRY, THOMAS, J.;KULIOPULOS, ATHAN;COVIC, LIDIJA |